Darzalex® (daratumumab)
for Multiple Myeloma

Darzalex (daratumumab) is a targeted therapy used to treat multiple myeloma by slowing or stopping cancer progression. It binds to CD38, a protein highly expressed on myeloma cells, helping destroy them and boost the immune system's response. Darzalex is a CD38 monoclonal antibody and may be used alone or with other treatments. It works to target and attack cancer cells while supporting immune function.

Heart
Medication Guide Icon Medication Guide
Patient Website Icon Patient Website
Efficacy Data Icon Efficacy Data
New Articles Icon New Articles
Savings and Support Icon Savings and Support
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Multiple Myeloma